Search company, investor...

Founded Year



Series A | Alive

Total Raised


Last Raised

$26M | 1 yr ago

Mosaic Score

+30 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Ellipsis Health

Ellipsis Health develops an artificial intelligence-powered, speech-based platform that aims to quantify and manage depression and anxiety symptoms.

Ellipsis Health Headquarters Location

118 2nd Street 2nd floor

San Francisco, California, 941015,

United States


ESPs containing Ellipsis Health

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Life Sciences / Biopharma Tech

The companies in this market develop measurable indicators of neurological function and mental health that can help guide treatment decisions and lead to improved patient outcomes. These vendors leverage a variety of data collection modalities, from wearables to digital devices.

Ellipsis Health named as Highflier among 13 other companies, including Aural Analytics, Mindstrong, and Altoida.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Ellipsis Health's Products & Differentiation

See Ellipsis Health's products and how their products differentiate from alternatives and competitors


    Vocai, Ellipsis Health's voice-powered AI tool, detects depression & anxiety during calls and telemedicine sessions supporting the following: Early Detection for Quick Triage Vocai passively analyzes patient voice in real-time and provides risk scores to providers, identifying costly patients who are falling through the cracks. Triage to Mental Health Support Vocai directly connects higher-risk members to mental health professionals. Lower-risk members are matched with evidence-based preventative care. Plugs into your existing call software Vocai works across all channels - our API and SDKs provide flexible integration wherever your providers work. Mental Health Monitoring Use Vocai to gather and analyze patient and population health data and facilitate value-based care. You can access VOCAI here:


    Our artificial intelligence provides clinical-grade results using both NLP and Acoustic machine learning models. Our models do not require a baseline from the user to perform. 

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.


    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Research containing Ellipsis Health

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Ellipsis Health in 1 CB Insights research brief, most recently on Aug 17, 2022.

Expert Collections containing Ellipsis Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Ellipsis Health is included in 9 Expert Collections, including Digital Health.


Digital Health

21,952 items

Startups recreating how healthcare is delivered


Mental Health Tech

1,376 items

This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.


Artificial Intelligence

9,391 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Medical Devices

8,490 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



2,853 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.


Health Monitoring & Diagnostics

986 items

Companies offering smartphone-based health monitoring & diagnostic solutions (using native components of the smartphone, e.g. camera, microphone, accelerometer, gyroscope, etc.). Companies tagged as #SmartphoneBasedDiagnostics

Ellipsis Health Patents

Ellipsis Health has filed 8 patents.

The 3 most popular patent topics include:

  • Psychiatric diagnosis
  • Mood disorders
  • Clinical psychology tests
patents chart

Application Date

Grant Date


Related Topics




Natural language processing, Psychiatric diagnosis, Computational linguistics, Abnormal psychology, Mood disorders


Application Date


Grant Date



Related Topics

Natural language processing, Psychiatric diagnosis, Computational linguistics, Abnormal psychology, Mood disorders



Latest Ellipsis Health News

What Is Femtech, and How Is It Evolving in Healthcare?

Sep 14, 2022

The field of women’s health isn’t new, and the term ‘femtech’ only became popular in 2016. Since then, the field has grown, but women are still underrepresented in the health IT market. by Listen   The field of women’s health has been around for millennia. The Kahun Gynaecological Papyrus , which addresses conception, pregnancy and contraception, dates to around1800 B.C. and is one of the oldest known Egyptian medical documents . However, “femtech” is a new term in women’s health. Clue founder Ida Tin coined the term in 2016, which legitimized an area of technology innovation often ignored by investors. “Like other female health tech entrepreneurs, she noticed that mostly male-dominated investment firms struggle with the language to discuss female biological health. Soon after, the #MeToo movement caught fire on social media worldwide and helped popularize ‘femtech,’ together with public demand for improved gender equity in technology and venture capital,” says Susan Solinsky, director of HITLAB’s Women’s Health Tech initiative and co-founder and chief growth officer of Ellipsis Health . “The introduction of the term ‘femtech’ was a step toward more open discussions. Eventually, the investment community recognized that women’s health is a subcategory of digital health worthy of significant investment.” More women are joining STEM fields , which is leading to more women with the skills to create solutions that didn’t exist before. “We’re seeing a direct relationship between solutions for women’s health and the number of women in STEM,” says Brittany Barreto , co-founder and executive director of the nonprofit FemTech Focus . Adoption of femtech has risen alongside the adoption of hybrid and virtual care delivery models during the pandemic as patients and providers have become more comfortable with digital health technologies. In its “ Femtech Landscape 2021 ” report, Femtech Focus notes that femtech includes reproductive, menstrual, sexual, pelvic floor, vaginal, oncological, bone, brain, autoimmune and heart health. Femtech products typically fall under one of six categories: medical device, software, therapeutic drug, consumer product, consumer service or consumer app. No matter the modality, femtech companies are disrupting the ways healthcare providers reach patients. Femtech Explained: A Look at Health IT Use Cases Over the years, femtech has evolved beyond female reproductive health to encompass a broader scope of health. It can now refer to technology related to health conditions that affect women differently or disproportionately, such as autoimmune disorders, migraines and cardiovascular disease. “When 80 to 90 percent of people with a disease or disorder are women, then it’s a women’s health issue,” says Barreto. She says that disease can also present differently in men and women, which is something that needs to be considered when creating diagnostic tools. It’s also important to consider how gender bias can impact care delivery in areas such as pain management and mental health. “The COVID-19 pandemic drew our nation’s attention to many gaps in mental healthcare access and delivery in our country,” she says. “We know now that women are nearly twice as likely as men to be diagnosed with depression. Gender is increasingly acknowledged as a social determinant of mental health in the U.S., and more investment in this area is critical to helping us better understand the root causes behind these inequities.” Many femtech companies are providing individualized care programs with a unique understanding of the factors that affect women’s mental health. One such technology, LunaJoy , offers online, holistic mental health counseling and therapy for women. Another is Flo , an app designed to help women manage their menstrual cycles in addition to tracking and monitoring moods. Femtech companies have the opportunity to screen and monitor gender-specific mental health issues and provide digital interventions, according to Solinsky. She says femtech should design mental health interventions for women experiencing antepartum and postpartum depression, premenstrual dysphoric disorder, complex menopause issues, perinatal mental health issues, eating disorders, traumatic births or miscarriages, and intimate partner violence or gender-based violence. Barreto says there are several new femtech solutions she’s excited about, including Rosy , an app focused on sexual dysfunction founded by an OB-GYN; Juno Bio , an at-home vaginal microbiome test; Irth , an app where women of color can review doctors and hospitals based on their prenatal, birthing, postpartum and pediatric experiences; and NUA Surgical , an Irish femtech startup that developed the SteriCISION C-section Retractor to improve access and visibility during caesarean deliveries. Tips on Femtech Implementation for Healthcare Organizations Femtech adoption is not only happening on a patient level. Many traditional, brick-and-mortar healthcare organizations are adopting femtech. For example, Oova is an at-home hormone test paired with a smartphone app that translates test results into a personalized fertility plan. It was created in collaboration with the Mount Sinai Hospital in New York by a doctor who personally experienced challenges in her fertility journey. “Once patients receive their results within the app, their hormone levels and any relevant symptoms are reported in rea time on the Oova provider dashboard and can be viewed at any of the 100 partner fertility clinics across the U.S.,” says Solinsky. Another femtech company, Babyscripts , offers a software that logs maternal health vitals using remote monitoring. Barreto says the company offers its app as a white-label product for healthcare organizations. “Many women will have more faith in a technology if it’s offered through their personal doctors,” she adds. “It’s a great business model, but these companies need more funding to achieve further success.” To implement technologies that impact women’s health outcomes positively, we need accurate, quality data about conditions that pertain exclusively to women.” Susan Solinsky Director, HITLAB’s Women’s Health Tech initiative; Co-Founder and CGO, Ellipsis Health “To implement technologies that impact women’s health outcomes positively, we need accurate, quality data about conditions that pertain exclusively to women, such as contraception, fertility, maternal health, gynecology, menopause and women’s oncology, and general health conditions where women’s differences are not comprehensively known or studied, such as Alzheimer’s, cardiovascular conditions, autoimmune diseases, migraines, and osteoporosis,” says Solinsky. She explains that innovation depends on representation, which means transparency into which groups receive early access to interventions and clinical trials is important. However, Solinsky is optimistic about opportunities to use digital health tools to collect de-identified patient data for real-world evidence research. “There are also new research channels being built, such as at-home, tech-based testing and monitoring solutions for a wide range of acute and chronic women’s health conditions, that contribute to a growing pool of more diverse, patient-generated health data and support the future of individualized care,” she says. Hiring a femtech or health IT consultant can also help healthcare organizations identify the right solutions from companies that can meet their needs. Addressing Patient Data Privacy in Women’s Digital Health Many femtech companies have increased their data privacy efforts in the wake of the U.S. Supreme Court’s Roe v. Wade decision in June . While data privacy has always been a concern, the court’s decision has upped the stakes for femtech companies collecting patient data about menstrual cycles as well as other types of data relevant to pregnancy and abortion. “The decision opens the door to legal ramifications for women seeking abortions in many states. It raises serious concerns about whether abortion or even menstrual cycle-related data from women's health apps could be subpoenaed and used for criminal prosecution,” says Solinsky. Many femtech companies are underfunded, according to Barreto, meaning that a lot of the app privacy policies are “cookie-cutter.” “If they had the resources, they could have awesome privacy policies,” she says. However, “for the most part, regardless of policy, law enforcement can subpoena data.” She recommends that those who menstruate avoid logging missing periods or sending Facebook messages about related topics to avoid that data being used against them as femtech companies work to address the situation. Those who are concerned about their data being shared can reach out to femtech companies to ask about their privacy policies. Solinsky is worried that investors and stakeholders will see data privacy concerns as a barrier for early-stage femtech companies looking to scale across states. “Still, I have also seen a wave of encouraging support from the investment community,” she says. While femtech companies find ways to further protect patient data in the face of policy changes, Solinsky says, accurate data collection enables accurate diagnostics, better care delivery and more comprehensive research, in addition to the overall reduction in care costs. The Future of Femtech in Healthcare The definition of femtech is still evolving. Much more investment in research and innovation is needed to understand and address this complex digital health sector fully, says Solinsky. Barreto says that it’s important to look at the femtech ecosystem holistically to identify areas of heavy saturation or underrepresentation. Heart disease is the No. 1 killer of women , but Barreto notes that there are few femtech companies focused specifically on heart disease. And while there are dozens of menstruation-focused femtech solutions, “ period poverty ” is still a major problem in the U.S. Historically, with a lack of billing codes for women’s health solutions, femtech startups had to focus on direct-to-consumer products, which were often expensive. This resulted in solutions often designed for affluent white women who were able to afford them rather than solutions focused on improving health equity for all.

Ellipsis Health Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Ellipsis Health Rank

  • When was Ellipsis Health founded?

    Ellipsis Health was founded in 2017.

  • Where is Ellipsis Health's headquarters?

    Ellipsis Health's headquarters is located at 118 2nd Street, San Francisco.

  • What is Ellipsis Health's latest funding round?

    Ellipsis Health's latest funding round is Series A.

  • How much did Ellipsis Health raise?

    Ellipsis Health raised a total of $30.27M.

  • Who are the investors of Ellipsis Health?

    Investors of Ellipsis Health include Divesh Makan, Luminous VC, What If Ventures, TIME Ventures, Khosla Ventures and 17 more.

  • Who are Ellipsis Health's competitors?

    Competitors of Ellipsis Health include Aural Analytics and 7 more.

  • What products does Ellipsis Health offer?

    Ellipsis Health's products include VOCAI and 1 more.

  • Who are Ellipsis Health's customers?

    Customers of Ellipsis Health include Cigna International, Headspace and Ceras Health.

You May Also Like

Sonde Health Logo
Sonde Health

Sonde Health is a digital medicine company that develops a voice-based technology with the potential to monitor and diagnose mental and physical health. Sonde's technology works by sensing and analyzing subtle changes in the voice to create a range of persistent brain, muscle, and respiratory health measurements that provide a more complete picture of health in just seconds.

Winterlight Labs Logo
Winterlight Labs

WinterLight Labs has developed a technology that aims to quickly and accurately quantify speech and language patterns. With this technology, the company aims to help detect and monitor cognitive and mental diseases such as dementia and Alzheimer's.

Aural Analytics Logo
Aural Analytics

Aural Analytics uses speech to detect subtle but clinically meaningful changes in brain health. The platform is completely agnostic to disease, device, location and language and powers applications throughout the world. Aural Analytics was founded in 2015 and is based in Scottsdale, Arizona.

Vocalis Health Logo
Vocalis Health

Vocalis Health is a vocal biomarker company that uses voice to detect, diagnose, and monitor patient health.


Kintsugi offers a self-journaling app that uses machine learning and clinically-proven techniques to tackle daily stress, anxiety and depression.

Modality.AI Logo

Modality.AI detects health conditions using conversational AI. The company's platform analyzes the video of a user (recorded while the user interacts with an on-screen avatar) for facial movements and speech patterns to evaluate changes in neurological diseases which provides objective data to clinical drug trials.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.